New York, NY -- (SBWIRE) -- 01/02/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Neuralstem, Inc (NYSEMKT:CUR), Hawaiian Holdings, Inc (NASDAQ:HA), Global Cash Access Holdings, Inc (NYSE:GCA), Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)
Neuralstem, Inc (NYSEMKT:CUR) showed a volume of 1.08 million shares by the end of last trade whereas the average volume of the stock remained 755,106.00 shares. The stock opened the session at $2.98 but then moved to $2.91. At that price, the stock showed a negative performance of -1.02%. Neuralstem, Inc. is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs. The Company has developed and maintains a portfolio of patents and patent applications that form base for its research and development efforts in the area of neural stem cell research.
Will CUR Get Buyers Even After The Recent Rally? Find Out Here
Hawaiian Holdings, Inc (NASDAQ:HA) opened the session at $9.46and closed the session at $9.63. The stock showed a positive performance of 1.37% in previous trading session. Hawaiian Holdings, Inc. (Holdings), is a holding company whose primary asset is the sole ownership of all issued and outstanding shares of common stock of Hawaiian Airlines, Inc. (Hawaiian). Hawaiian is engaged in the scheduled air transportation of passengers and cargo amongst the Hawaiian Islands (the interisland routes), between the Hawaiian Islands and certain cities in the United States (the North America routes), and between the Hawaiian Islands and the South Pacific, Australia and Asia (the the International routes). In addition,
For How Long HA will fight for Profitability? Read This Trend Analysis report
Global Cash Access Holdings, Inc (NYSE:GCA) opened the session at $10.03and closed the session at $0.276. The stock showed a positive performance of 0.71% in previous trading session. The beta of the stock remained 1.28. Global Cash Access Holdings, Inc. (Holdings) is a holding company. The Company is a global provider of cash access and data intelligence services and solutions to the gaming industry. The Company operates in three segments: cash advance, ATM and check services. Its cash access products and services enable three primary types of electronic payment transactions: automated teller machine (ATM) cash withdrawals,
Why Should Investors Buy GCA After The Recent Gain? Just Go Here and Find Out
Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) the stock decreased -0.61% and finished the session at $1.80. Traded with volume of 1.06 million shares in the prior session and the average volume of the stock remained 1.34 million shares. The beta of the stock remained1.80. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets.
Will LXRX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)